Spartan Capital Securities LLC

ChapmanAlbin is investigating Spartan Capital Securities LLC (CRD 146251) after FINRA accused the firm of missing glaring red flags of churning and also accused the firm, CEO John Dennis Lowry, and former CCO Kim Marie Monchik of private placement misconduct involving due diligence, disclosure, and conflicts issues. The common investor concern is straightforward: when a firm’s compensation or internal interests come first, customers can be left with unsuitable recommendations, excessive trading costs, or delayed exits while insiders benefit.

Firm Snapshot

Key Facts and Public Records

• FINRA BrokerCheck detailed firm report (PDF): Spartan Capital Securities LLC (CRD 146251).
• FINRA OHO complaint: Spartan Capital Securities LLC, John Dennis Lowry, and Kim Marie Monchik, Disciplinary Proceeding No. 2021071714201.
• FINRA BrokerCheck disclosure summary referencing a pending December 2025 complaint alleging widespread churning and supervision failures.
• FINRA BrokerCheck disclosure summary referencing a pending November 2025 complaint alleging unsuitable private placement recommendations, Reg BI issues, conflicts concerns, and due diligence failures tied to Atlas Funds offerings.
• Additional background articles provided by the user for context only, not as primary cited sources.

Further Details

FINRA and BrokerCheck summary and key findings

Spartan’s current BrokerCheck report shows a meaningful disclosure history, including pending, final, and appeal-stage regulatory matters. The most recent public items in the report include a December 2025 FINRA complaint alleging widespread churning and excessive trading, and a November 2025 FINRA complaint centered on private placement recommendations and conflict disclosures. The firm’s BrokerCheck report also identifies John Dennis Lowry as CEO/Managing Member and lists Kim Marie Monchik as CCO, which helps connect the firm report to the named individuals in the FINRA complaint.

Regulatory and enforcement actions

The December 2025 pending FINRA complaint alleges that Spartan generated millions in revenue through widespread churning and that the firm, along with supervisory personnel, failed to reasonably investigate and address red flags of excessive trading. Separately, the November 2025 pending FINRA complaint alleges that the firm recommended more than $24 million in private placements to 191 customers, generated more than $2.4 million in placement fees, and failed to conduct reasonable due diligence, maintain records of that diligence, or fully disclose leadership conflicts tied to the Atlas Funds offerings. An earlier FINRA complaint from 2021 specifically named Spartan, CEO John Dennis Lowry, and then-CCO Kim Marie Monchik, and alleged a different kind of conflict problem: that the firm and certain employees used a faster “deemed owned” sale process for their own restricted shares while customers were left in a slower queue and watched the price fall.

Why these allegations matter to investors

These records describe a few recurring risk themes. One is possible commission-driven trading, where frequent in-and-out transactions can rack up costs and make it very hard for an account to keep pace. Another is private placement risk, especially when offerings are affiliated with insiders or depend on limited disclosures and thin due diligence. A third is conflict management: if a firm or its leadership stands to benefit in ways customers do not fully understand, investors may not be getting recommendations that are truly in their best interest. In practical terms, investors should look at whether trading volume, commissions, markups, concentration, or offering documents matched what they were told at the time.

What investors can do and how ChapmanAlbin can help

If you invested through Spartan Capital Securities LLC and experienced losses tied to heavy trading, private placements, or recommendations that seemed to benefit the firm more than you, preserve your records and consider getting your account reviewed. Depending on the facts, claims may involve failure to supervise, misrepresentation and omission, churning, unsuitability, or Regulation Best Interest issues.

Common Warning Signs

• Frequent trading that produced large commissions, fees, or markups without a clear benefit to your account.
• A recommendation to invest in a private placement or affiliated offering that was described as exclusive, urgent, or unusually attractive without balanced risk discussion.
• Documents that did not clearly explain who controlled the offering, who was being compensated, or how the investment was sourced.
• High turnover, repeated in-and-out trading, or account activity that looked far more aggressive than your stated objectives or risk tolerance.
• A situation where insiders or firm personnel appeared to have better information, faster access, or more favorable exit opportunities than customers.

Documents to Gather

• Account statements and trade confirmations for the full period at issue.
• Private placement memoranda, subscription agreements, supplements, side letters, and any marketing decks or pitch emails.
• Notes from calls or meetings, plus texts and emails with brokers or firm personnel.
• Commission, markup, fee, and cost information if available.
• Any complaints you made to the firm and any responses you received.
• Records showing your investment objectives, risk tolerance, net worth, and liquidity needs at the time of the recommendations.

FAQs

What is churning?

Churning usually means excessive trading in an account primarily to generate commissions or other compensation, rather than to help the investor reach legitimate goals. It often shows up through high turnover, heavy costs, and a pattern of in-and-out transactions.

Why do private placement conflicts matter?

Private placements can already be harder to evaluate because they are less transparent and less liquid than many public investments. When the offering is tied to insiders, affiliated entities, or undisclosed compensation, the risk goes up because the recommendation may be influenced by the firm’s own financial interest.

Does a FINRA complaint mean the allegations are proven?

No. A complaint is still an allegation. But it can still be important because it describes the conduct regulators believe is serious enough to charge, and it can help investors spot patterns they should review in their own accounts.

What should I review first if I invested through Spartan?

Start with your statements, confirmations, offering documents, emails, and notes from calls. Look for unusually active trading, large commissions or markups, recommendations involving affiliated offerings, and anything that was not clearly explained before you invested.

Disclaimer

This page is for informational purposes only and is not legal advice. Past outcomes are not a guarantee of future results. Every matter depends on its own facts and evidence.